Cargando…
Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice
For a nationwide real-word data study on the application of predictive mutation testing of patients with colorectal cancer (CRC) for anti-epidermal growth factor receptor (EGFR) therapy stratification, pathology data were collected from the Dutch Pathology Registry from October 2017 until June 2019...
Autores principales: | Steeghs, Elisabeth M P, Vink, Geraldine R, Elferink, Marloes A G, Voorham, Quirinus J M, Gelderblom, Hans, Nagtegaal, Iris D, Grünberg, Katrien, Ligtenberg, Marjolijn J L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510427/ https://www.ncbi.nlm.nih.gov/pubmed/34675090 http://dx.doi.org/10.1136/jclinpath-2021-207865 |
Ejemplares similares
-
Nationwide evaluation of mutation-tailored treatment of gastrointestinal stromal tumors in daily clinical practice
por: Steeghs, Elisabeth M. P., et al.
Publicado: (2021) -
Nationwide implementation of a multifaceted tailored strategy to improve uptake of standardized structured reporting in pathology: an effect and process evaluation
por: Swillens, Julie E. M., et al.
Publicado: (2022) -
Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2022) -
High sensitivity of both sequencing and real-time PCR analysis of KRAS mutations in colorectal cancer tissue
por: Tol, Jolien, et al.
Publicado: (2010) -
Limited impact of the COVID-19 pandemic on colorectal cancer care in the Netherlands in 2020
por: Meijer, Joyce, et al.
Publicado: (2022)